首页> 外文期刊>The Open Conference Proceedings Journal >Synthesis of 4-Methoxybenzoylhydrazone Derivatives and Evaulation of Their Antiglycation Activity
【24h】

Synthesis of 4-Methoxybenzoylhydrazone Derivatives and Evaulation of Their Antiglycation Activity

机译:4-甲氧基苯甲酰Hy衍生物的合成及其抗糖化活性的评价

获取原文
       

摘要

4-Methoxybenzoylhydrazone derivatives (1-30) were synthesized from 4-methoxybenzoylhydrazide which were obtained frommethyl-4-methoxybenzoate by refluxing with hydrazine hydrate for 5 h. 4-Methoxybenzoylhydrazones derivatives wereprepared by condensing 4-methoxybenzoylhydrazide with different aromatic aldehydes under reflux condition in ethanol for 3-4 h. The compounds 1-30 showed varying degree of antiglycation activitiy, with IC50 values ranging between 216.52 ± 4.2-748.71 ± 7.8 μM, when compared to standard Rutin (294.46 ± 1.50 μM). Compounds 1, 6, 7, 11 and 3 (IC50 = 216.52 ± 4.2μM), (IC50 = 227.75 ± 0.53 μM), (IC50 = 242.53 ± 6.1 μM), (IC50 = 287.79 ± 1.59 μM), and (IC50 = 289.58 ± 2.64 μM) showedbetter activities than standard Rutin (294.46 ± 1.50 μM). The compounds 4, 8, 2 and 12 (IC50 = 307.1 ± 6.08 μM), (IC50 =347.62 ± 5.8 μM), (IC50 = 394.76 ± 3.35 μM) and (IC50 = 399.90 ± 7.9μM) showed good activity. The compounds 5 and 17(IC50 = 420.40 ± 3.3 μM), and (IC50 = 474.97 ± 19.14 μM) showed moderate activities. The compounds 14, 10, 18 and 15 (IC50= 649.18 ± 18.5 μM), (IC50 = 657.75 ± 14.0 μM), (IC50 = 718.96 ± 10.7 μM), and (IC50 = 748.71 ± 7.8 μM) showed weakactivities. The compounds 9, 13 and 18-30 showed inhibition less than 50% therefore they were not evaluated for IC50. Thus,these compounds are potential molecules for the development of new derivatives for glycation inhibition..
机译:由4-甲氧基苯甲酰肼与4-水合肼回流5小时,由4-甲氧基苯甲酰甲酯合成4-甲氧基苯甲酰hydr衍生物(1-30)。将4-甲氧基苯甲酰肼与不同的芳香醛在乙醇中回流条件下缩合3-4小时,制得4-甲氧基苯甲酰肼衍生物。与标准芦丁(294.46±1.50μM)相比,化合物1-30显示出不同程度的抗糖基化活性,IC50值在216.52±4.2-748.71±7.8μM之间。化合物1、6、7、11和3(IC50 = 216.52±4.2μM),(IC50 = 227.75±0.53μM),(IC50 = 242.53±6.1μM),(IC50 = 287.79±1.59μM)和(IC50 = 289.58±2.64μM)的活性优于标准芦丁(294.46±1.50μM)。化合物4、8、2和12(IC50 = 307.1±6.08μM),(IC50 = 347.62±5.8μM),(IC50 = 394.76±3.35μM)和(IC50 = 399.90±7.9μM)显示出良好的活性。化合物5和17(IC50 = 420.40±3.3μM)和(IC50 = 474.97±19.14μM)显示中等活性。化合物14、10、18和15(IC50 = 649.18±18.5μM),(IC50 = 657.75±14.0μM),(IC50 = 718.96±10.7μM)和(IC50 = 748.71±7.8μM)显示弱活性。化合物9、13和18-30的抑制作用小于50%,因此未评估其IC50。因此,这些化合物是用于开发新的糖基化抑制衍生物的潜在分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号